These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 9313891

  • 1. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS, Trimmer PA, Khan SM, Tinklepaugh DL, Bennett JP.
    Brain Res; 1997 Aug 15; 765(2):189-97. PubMed ID: 9313891
    [Abstract] [Full Text] [Related]

  • 2. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Synapse; 1993 Jun 15; 14(2):184-94. PubMed ID: 8332947
    [Abstract] [Full Text] [Related]

  • 3. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
    Tanji H, Araki T, Nagasawa H, Itoyama Y.
    Brain Res; 1999 Apr 10; 824(2):224-31. PubMed ID: 10196452
    [Abstract] [Full Text] [Related]

  • 4. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.
    Gerfen CR, Keefe KA, Gauda EB.
    J Neurosci; 1995 Dec 10; 15(12):8167-76. PubMed ID: 8613751
    [Abstract] [Full Text] [Related]

  • 5. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA, Rothblat DS, Joyce JN, Schneider JS.
    Synapse; 1995 Jan 10; 19(1):46-55. PubMed ID: 7709343
    [Abstract] [Full Text] [Related]

  • 6. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB, Bennett JP.
    Brain Res Dev Brain Res; 1996 Jul 20; 94(2):109-20. PubMed ID: 8836569
    [Abstract] [Full Text] [Related]

  • 7. Development of striatal dopaminergic function. II: Dopaminergic regulation of transcription of the immediate early gene zif268 and of D1 (D1a) and D2 (D2a) receptors during pre- and postnatal development.
    Jung AB, Bennett JP.
    Brain Res Dev Brain Res; 1996 Jul 20; 94(2):121-32. PubMed ID: 8836570
    [Abstract] [Full Text] [Related]

  • 8. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 20; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N, Jourdain VA, Morissette M, Grégoire L, Di Paolo T.
    Neuropharmacology; 2014 Apr 20; 79():688-706. PubMed ID: 24456747
    [Abstract] [Full Text] [Related]

  • 10. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

  • 11. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS, Neal-Beliveau BS, Joyce JN.
    Brain Res Dev Brain Res; 1998 Nov 01; 111(1):99-106. PubMed ID: 9804909
    [Abstract] [Full Text] [Related]

  • 12. Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions.
    Smith TS, Bennett JP.
    Brain Res; 1997 Aug 15; 765(2):183-8. PubMed ID: 9313890
    [Abstract] [Full Text] [Related]

  • 13. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
    Gross CE, Ravenscroft P, Dovero S, Jaber M, Bioulac B, Bezard E.
    J Neurochem; 2003 Mar 15; 84(6):1246-55. PubMed ID: 12614325
    [Abstract] [Full Text] [Related]

  • 14. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D.
    BMC Biol; 2004 Oct 11; 2():22. PubMed ID: 15473914
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T.
    J Neurochem; 1999 Feb 11; 72(2):682-92. PubMed ID: 9930741
    [Abstract] [Full Text] [Related]

  • 16. Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.
    Goulet M, Morissette M, Calon F, Blanchet PJ, Falardeau P, Bédard PJ, Di Paolo T.
    Neuroscience; 1997 Jul 11; 79(2):497-507. PubMed ID: 9200732
    [Abstract] [Full Text] [Related]

  • 17. Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions.
    Khan SM, Smith TS, Bennett JP.
    J Neurosci Res; 1999 Jan 01; 55(1):71-9. PubMed ID: 9890435
    [Abstract] [Full Text] [Related]

  • 18. Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons.
    Todd RD, Carl J, Harmon S, O'Malley KL, Perlmutter JS.
    J Neurosci; 1996 Dec 01; 16(23):7776-82. PubMed ID: 8922433
    [Abstract] [Full Text] [Related]

  • 19. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M, Blanchard V, Raisman-Vozari R, Feuerstein C, Agid Y, Javoy-Agid F, Savasta M.
    Eur J Neurosci; 1996 Dec 01; 8(12):2511-20. PubMed ID: 8996800
    [Abstract] [Full Text] [Related]

  • 20. Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.
    Gagnon C, Gomez-Mancilla B, Bédard PJ, Di Paolo T.
    Neurosci Lett; 1993 Nov 26; 163(1):31-5. PubMed ID: 7905197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.